24 HR oxcarbazepine 300 MG Extended Release Oral Tablet
- RxCUI
- 1365842
- RxNorm name
- 24 HR oxcarbazepine 300 MG Extended Release Oral Tablet
- Display name
- 24 HR oxcarbazepine 300 MG Extended Release Oral Tablet
- Full name
- 24 HR oxcarbazepine 300 MG Extended Release Oral Tablet
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:14
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxcarbazepine | OXCARBAZEPINE | Ajanta Pharma USA Inc. | d947e9b1-2a15-4048-bb4e-fe56b6851848 | 2025-11-30 | Warnings, Adverse reactions | 1365842 |
| OXTELLAR XR | OXCARBAZEPINE | Supernus Pharmaceuticals, Inc. | aa610e56-1d1d-11e1-8bc2-0800200c9a66 | 2025-10-22 | Warnings, Adverse reactions | 1365842 |
| OXCARBAZEPINE | OXCARBAZEPINE | Apotex Corp. | a20e4a95-8ee1-e702-003e-e353ec1ee133 | 2025-09-19 | Warnings, Adverse reactions | 1365842 |
| Oxcarbazepine | OXCARBAZEPINE | Ingenus Pharmaceuticals, LLC | 70798ca9-0eda-49c0-8a7c-b775b6ae3d69 | 2025-04-12 | Warnings, Adverse reactions | 1365842 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| aa610e56-1d1d-11e1-8bc2-0800200c9a66 | OXcarbazepine 300 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR oxcarbazepine 300 MG Extended Release Oral Tablet [SCD] · oxcarbazepine 300 MG 24 HR Extended Release Oral Tablet [SY] | 3 | 21 | These highlights do not include all the information needed to use OXTELLAR XR ® safely and effectively. See full prescribing information for OXTELLAR XR ® . OXTELLAR XR ® (oxcarbazepine) extended-release tablets, for oral use Initial U.S. Approval: 2000 | 20251022 |
| a20e4a95-8ee1-e702-003e-e353ec1ee133 | OXcarbazepine 300 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR oxcarbazepine 300 MG Extended Release Oral Tablet [SCD] · oxcarbazepine 300 MG 24 HR Extended Release Oral Tablet [SY] | 3 | 6 | These highlights do not include all the information needed to use OXCARBAZEPINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for OXCARBAZEPINE EXTENDED-RELEASE TABLETS. OXCARBAZEPINE extended-release tablets, for oral use Initial U.S. Approval: 2000 | 20250919 |
| 70798ca9-0eda-49c0-8a7c-b775b6ae3d69 | OXcarbazepine 300 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR oxcarbazepine 300 MG Extended Release Oral Tablet [SCD] · oxcarbazepine 300 MG 24 HR Extended Release Oral Tablet [SY] | 3 | 6 | These highlights do not include all the information needed to use OXCARBAZEPINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for OXCARBAZEPINE EXTENDED-RELEASE TABLETS. OXCARBAZEPINE extended-release tablets, for oral use Initial U.S. Approval:2000 | 20250412 |
| d947e9b1-2a15-4048-bb4e-fe56b6851848 | OXcarbazepine 300 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR oxcarbazepine 300 MG Extended Release Oral Tablet [SCD] · oxcarbazepine 300 MG 24 HR Extended Release Oral Tablet [SY] | 3 | 4 | These highlights do not include all the information needed to use OXCARBAZEPINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for OXCARBAZEPINE EXTENDED-RELEASE TABLETS. OXCARBAZEPINE extended-release tablets, for oral use Initial U.S. Approval: 2000 | 20251130 |
| 5094cd69-e3e2-4222-bc2a-00090c43d3a2 | OXcarbazepine 300 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR oxcarbazepine 300 MG Extended Release Oral Tablet [SCD] · oxcarbazepine 300 MG 24 HR Extended Release Oral Tablet [SY] | 3 | 1 | These highlights do not include all the information needed to use OXCARBAZEPINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for OXCARBAZEPINE EXTENDED-RELEASE TABLETS. OXCARBAZEPINE extended-release tablets, for oral use Initial U.S. Approval: 2000 | 20240227 |